Delusions of parasitosis

Published on 19/03/2015 by admin

Filed under Dermatology

Last modified 19/03/2015

Print this page

This article have been viewed 1600 times

Delusions of parasitosis

Jillian W. Wong Millsop and John Y.M. Koo

Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports

(From Robles, D.T., Romm, S., Combs, H., Olson, J., Kirby, P., 2008. Delusional disorders in dermatology: a brief review. Dermatology Online Journal 14 (6), 2. ©2008.)

Delusions of parasitosis is a form of delusional disorder somatic type (known also as a monosymptomatic hypochondriacal psychosis), in which patients have a cutaneous dysesthesia that causes them to pick at their skin continuously, in order to ‘extract’ an organism or ‘foreign body’ they believe is present in their skin. The cutaneous findings that result from these attempts to dig out the suspected parasites range from normal skin to excoriations, picker’s nodules, and frank ulcerations. Patients develop elaborate and complex delusional ideations associated with their condition, and their fixed beliefs cannot be argued with reason. These patients often collect ‘samples’ in bottles, Ziploc® bags, jars, or slides of what is often lint, hair, debris, dead skin, and even common insects found in the home, using these specimens to provide ‘evidence’ to physicians of the alleged underlying cause of their condition. Many of these patients can also have tactile hallucinatory experiences that are compatible with their delusion. The most characteristic hallucinatory symptom they may experience is formication, which manifests as sensations of cutaneous crawling, biting, or stinging. Many also complain of pruritus. The condition has a bimodal age distribution, occurring in younger adults (men and women) and the elderly (mostly women). There can be secondary psychopathologies in delusions of parasitosis, such as depression and anxiety; these can be severe enough to cause the patient to commit suicide.

Management strategy

The physician should first establish therapeutic rapport with the patient. This begins with a thorough skin examination that sometimes entails deciding whether performing a biopsy may be worthwhile to establish rapport as patients frequently insist upon having a biopsy. To develop trust, it is imperative that the dermatologist examine these patients thoroughly and carry out a detailed medical history to exclude a frank skin condition (e.g., scabies incognito) or other possible organic conditions, such as substance abuse (e.g., cocaine), neurological (e.g., multiple sclerosis), endocrine (e.g., diabetes mellitus), hematologic/oncologic (e.g., lymphoma), nutritional (e.g., B₁₂ or folate deficiency), infectious (e.g., AIDS), cardiovascular (e.g., congestive heart failure) or renal disorders. The condition can also develop after the patient, relative, or pet has had a true parasitic infection, and so ruling out the presence of a real infestation is warranted. Importantly, when patients do not know the reason why they are itching, the clinician should consider a diagnosis other than delusions of parasitosis, because patients with delusions typically ‘know’ that infestation is causing their symptoms.

Examining various ‘specimens’ that the patient may bring to the dermatologist’s office under the microscope will demonstrate to the patient that his or her concerns are being taken seriously. One should not make any comments that may reinforce their delusional ideation, such as a statement that an organism responsible for the condition was found; an agreement such as this on the part of the clinician may ultimately render the patient more difficult to deal with by making them even more firmly fixated on their erroneous belief systems. On the other hand, by definition, rational argument or trying to talk a patient out of a delusion is both not possible (if the patient has a real delusion) and counterproductive. Dermatologists can acknowledge that they know the patient’s sensations and suffering are real, and that they will do everything they can to help. It is also important for the dermatologist to treat secondary skin changes in these patients. By doing so, the dermatologist will help to forge a therapeutic alliance with the patient. Dermatologists should consider soothing baths and topical agents such as steroid–anesthetic combinations or creams with menthol.

The most effective way to reverse delusional ideation is to start the patient on an antipsychotic medication. If this is described as an antipsychotic agent, however, few patients will accept the treatment. On the other hand, if this option is offered in a neutral way, emphasizing possible symptom reduction, such as reduced crawling, biting, or stinging sensations, while avoiding arguing over pathophysiology or the mechanism of action of these medications, patients may be eager to accept.

The medication traditionally used to treat delusions of parasitosis is the antipsychotic agent pimozide, a neuroleptic. This medication generally works very well, whether patients have classic delusions of parasitosis or merely formication, but are not delusional. The starting dose of pimozide is deliberately kept low at 0.5–1 mg/day to minimize the risk of side effects. The dose is gradually increased until the optimal clinical response is attained, as evidenced by reduced mental preoccupation, formication, and agitation. The dose of pimozide can be increased by as little as 0.5–1 mg increments, and as slowly as on a biweekly to monthly basis until significant clinical response is noted, which is usually evident by the time the dose is 3–5 mg daily. It is very rare that a patient will require a dose of more than 5 mg daily, and the use of more than 10 mg daily is almost unheard of in the treatment of delusions of parasitosis. Once the patient reaches a stable, well-tolerated dose, and agitation, mental preoccupation, and symptoms of formication have subsided, this dose should be maintained for a few months. During this time, if the patient continues to experience improvement, the dosage of pimozide can then be gradually reduced by as little as 1 mg every 2 to 4 weeks until the minimum necessary dosage is determined or the patient is tapered off the pimozide altogether.

If the clinical state deteriorates again in the future with a new episode of exacerbation of a delusional belief system and formication, the patient can be restarted on pimozide and again treated on a time-limited fashion to control the particular episode. Most patients can be treated on an episodic basis and can be tapered off pimozide after several months, but some require long-term low-dose maintenance treatment.

Buy Membership for Dermatology Category to continue reading. Learn more here

Related

Treatment of Skin Disease Comprehensive Therapeutic Strategies 4e